Last Updated on June 21, 2024 by
Alternative to Meds Editorial Team
Medically Reviewed by Dr Samuel Lee MD
Table of Contents:
- Video: Antidepressants FAQs
- What is Intranasal Esketamine/Spravato?
- What are the Side Effects of Esketamine?
- Intranasal Esketamine and Pregnancy
- Long-Term Results of Antidepressants
- A Note on Suicidality in Treating Depression
- Big Pharma’s Interest in Repurposing Psychedelics and Experimental Drugs for Mental Health
- Known Factors Contributing to Mental Health Symptoms
- Alternatives to Intranasal Esketamine at ATMC for Mental Wellness
- For More Information
With the introduction of intranasal esketamine for depression, we see an example of drug companies repurposing older drugs, including anesthetics and psychedelics to treat stubborn symptoms like MDD. Esketamine is only approved to treat patients who did not experience relief after at least 2 courses of treatment with “traditional” antidepressants.
As reported in the 2013 BMJ, a large share of people taking antidepressants do not benefit from drug-based therapy.21 This may have opened a large market share for novel treatments that are unproven, but profitable in the short term for their manufacturers. We know there’s a better approach.
Tired of experimenting when all you want is RESULTS?
We invite you to read about our high rates of success and the unique philosophy behind our programs which has helped so many achieve their mental health goals. Our treatment protocols are evidence-based, non-addictive, and non-toxic. The staff at the center are passionate about helping each client by designing a program that is uniquely tailored to the individual’s immediate needs and long-term goals. By addressing root causes in non harmful ways we have helped thousands of clients regain natural mental health over the past 17 years.
A human being is more than a bag of chemicals. Drug trials in the main are extremely short, and results are often inconclusive, even when they aren’t skewed by vested interests or written by authors employed by drug companies.20 Viewing mental health in this short-sighted way is a formula for failure, as the statistics clearly show. Limited efficacy of drug-based treatment, coupled with the likelihood of withdrawal phenomena when the drug is stopped are sound reasons to consider treatments that do aim for transformative results, without inflicting harm to the patient.12-16
Based on past performance and legal challenges from victims of dangerous psychiatric drugs, the most obvious driver for pharmaceutical drug companies appears to be making a profit, and avoiding bankruptcy if they can.
Alternative to Meds Center uses an extremely broad range of drug-free treatments for recovery of mental health symptoms that have persisted despite standard (or experimental) drug treatment. Where a person has found intranasal esketamine treatment unsatisfactory, or multiple medications, and desires to safely withdraw from these, the center offers specialized treatment programs to address the process in an orderly, comfortable way.
